Purdue Pharma Cuts More Than Half of U.S. Sales Staff Amid Opioid Crisis Post author:Sam Post published:February 12, 2018 Post category:BioPharma That announcement is a big change in the way Purdue has aggressively marketed OxyContin in the past. Source: BioSpace You Might Also Like Generex Biotechnology Corporation Release: Company Welcomes To Its Board Of Directors January 24, 2017 <b>Martin Shkreli's</b> Complaint Leads to a $100 Million FTC Settlement for This Biotech January 18, 2017 Dyadic Reports First Quarter 2017 Financial Results May 11, 2017
Generex Biotechnology Corporation Release: Company Welcomes To Its Board Of Directors January 24, 2017
<b>Martin Shkreli's</b> Complaint Leads to a $100 Million FTC Settlement for This Biotech January 18, 2017